Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2001-04-06 | Jeffrey E. Keisling serves as Vice President of Information Services of Wyeth-Ayerst Pharmaceuticals, a position he has held since September 2000. From December of 1998 through September of 2000, Mr. Keisling served as Senior Vice President and Chief Information Officer of Advanta Corporation. Mr. Keisling served as the Vice President and Chief Information Officer of Rhone-Poulenc Rorer Pharmaceuticals from January of 1994 to October of 1998. |
| 2002-04-08 | Jeffrey E. Keisling (3)(4)..... 45 1999 2005 (3) Member of the Audit Committee. (4) Member of the Compensation Committee. The current members of the Audit Committee are Messrs. Huston (Chairman), Keisling and Wix. The current members of the Compensation Committee are Messrs. Bahash (Chairman), Keisling, and Wix. Directors who are not officers or employees of the Company receive, upon initial election to the Board, an option to purchase 15,000 shares of Common Stock. Non-employee directors receive a fee of $3,000 for each regularly scheduled Board meeting attended in person and $1,500 for each regularly scheduled Board meeting attended by telephone. Committee members receive $750 for each regularly scheduled committee meeting attended, whether in person or otherwise. All directors are reimbursed for travel expenses incurred in connection with attending board and committee meetings. |
| 2003-04-07 | Member of the Compensation Committee. |
| 2004-04-01 | Jeffrey E. Keisling serves as Vice President of Information Services of Wyeth Pharmaceuticals, a position he has held since September 2000. From December 1998 through September 2000, Mr. Keisling served as Senior Vice President and Chief Information Officer of Advanta Corporation. |
| 2005-04-01 | Jeffrey E. Keisling, age 48, director since 1999, member of the Compensation Committee, independent director. "The current members of the Compensation Committee are Messrs. Keisling (Chairman), Hamlin and Wix." "Directors who are not officers or employees of the Company (Outside Directors) receive, upon initial election to the Board, an option to purchase 20,000 shares of common stock. Outside Directors also receive annual option grants. An Outside Director who serves as a committee chairman receives an option to purchase 10,000 shares of common stock each year and all other Outside Directors receive an option to purchase 7,500 shares of common stock each year." No specific total annual compensation in USD stated. |
Data sourced from SEC filings. Last updated: 2026-03-09